CIPLA vs INDSWFTLAB: Stock Comparison
Cipla Ltd vs Ind-Swift Laboratories Limited
Live data: 22 July 2026, 2:34 PM IST • Source: NSE and company filings
Cipla Ltd is the larger company by market capitalisation. Cipla Ltd shows a lower P/E, a higher ROE and a higher dividend yield, while Ind-Swift Laboratories Limited shows lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Cipla Ltd and Ind-Swift Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| Live Price | ₹1,410.9 | ₹234.43 |
| Day Change | -1.51% | -1.33% |
| Volume | 12.88 L | 3.69 L |
| 52-Week High | ₹1,673 | ₹248.45 |
| 52-Week Low | ₹1,165.7 | ₹87.15 |
| Distance from 52W High | -15.67% | -5.64% |
Valuation
| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| Market Cap | ₹1.14 L Cr | ₹2,034 Cr |
| P/E Ratio | 29.83x | 50.25x |
| P/B Ratio | 3.36x | 1.5x |
| EPS | ₹48.01 | ₹4.84 |
| Book Value | ₹426.25 | ₹165.77 |
| Dividend Yield | 0.9% | 0% |
Growth
| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| Revenue Growth (TTM YoY) | -2.1% | -66.6% |
| EPS Growth (TTM YoY) | -54.6% | -94.8% |
| Qtr Sales Growth | -2.8% | 22.8% |
| Qtr Profit Growth | -54.6% | 9.35% |
Profitability & Leverage
| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| ROE | 11.6% | 3.87% |
| ROCE | 15.5% | 4.7% |
| Net Margin | 13.96% | 41.4% |
| Operating Margin | 20.9% | 7.03% |
| Debt to Equity | 0.02x | 0.01x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | CIPLA | INDSWFTLAB |
|---|---|---|
| Promoter Holding | 9.17% | 42.99%▲ 3.49 pp |
| FII Holding | 22.56%▼ 1.37 pp | 13.88%▼ 0.45 pp |
| DII Holding | 31.97%▲ 1.25 pp | 0%▼ 0.68 pp |
| Public Holding | 16.25%▲ 0.12 pp | 43.12%▼ 2.38 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Cipla Ltd and Ind-Swift Laboratories Limited.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.